P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation

Molecular Biology of the Cell

Volumn 23, Issue 8, 2012, Pages 1582-1592

  Li, Ping ^a   Goto, Hidemasa ^a,b   Kasahara, Kousuke ^a,c   Matsuyama, Makoto ^a   Wang, Zhonghua ^a   Yatabe, Yasushi ^a   Kiyono, Tohru ^d   Inagaki, Masaki ^a,b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; ATR PROTEIN; BI D1870; CHECKPOINT KINASE 1; MK 2206; PROTEIN; PROTEIN P90; PROTEIN SERINE THREONINE KINASE INHIBITOR; S6 KINASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; CELL CYCLE PROGRESSION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MONITORING; MUTATION; PRIORITY JOURNAL; STIMULATION; STOICHIOMETRY; ULTRAVIOLET IRRADIATION;

CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; GENOMIC INSTABILITY; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA INTERFERENCE; RNA, SMALL INTERFERING;

ATAXIA TELANGIECTASIA;

EID: 84859708296     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-10-0883     Document Type: Article

References (55)

1. Anjum R, Blenis J (2008). The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9, 747-758.
2. Bartek J, Bartkova J, Lukas J (2007). DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26, 7773-7779. (Pubitemid 350242463)
3. Bellacosa A, Chan TO, Ahmed NN, Datta K, Malstrom S, Stokoe D, McCormick F, Feng J, Tsichlis P (1998). Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17, 313-325. (Pubitemid 28383008)
4. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999). Cell survival promoted by the Ras-MAPK signaling pathway by transcription- dependent and -independent mechanisms. Science 286, 1358-1362.
5. Branzei D, Foiani M (2008). Regulation of DNA repair throughout the cell cycle. Nature Rev 9, 297-308. (Pubitemid 351430844)
6. Cargnello M, Roux PP (2011). Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75, 50-83.
7. Ciccia A, Elledge SJ (2010). The DNA damage response: making it safe to play with knives. Mol Cell 40, 179-204.
8. Cimprich KA, Cortez D (2008). ATR: an essential regulator of genome integrity. Nature Rev 9, 616-627. (Pubitemid 352032926)
9. Engelman JA (2009). Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9, 550-562.
10. Enomoto M, Goto H, Tomono Y, Kasahara K, Tsujimura K, Kiyono T, Inagaki M (2009). Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2/M transition. J Biol Chem 284, 34223-34230.
11. Flynn RL, Zou L (2011). ATR: a master conductor of cellular responses to DNA replication stress. Trends Biochem Sci 36, 133-140.
12. Goto H, Inagaki M (2007). Production of a site- and phosphorylation state-specific antibody. Nature Protoc 2, 2574-2581.
13. Halazonetis TD, Gorgoulis VG, Bartek J (2008). An oncogene-induced DNA damage model for cancer development. Science 319, 1352-1355. (Pubitemid 351354863)
14. Henry MK, Lynch JT, Eapen AK, Quelle FW (2001). DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway. Blood 98, 834-841.
15. Ibi M et al. (2011). Trichoplein controls microtubule anchoring at the centrosome by binding to Odf2 and ninein. J Cell Sci 124, 857-864.
16. Ikegami Y, Goto H, Kiyono T, Enomoto M, Kasahara K, Tomono Y, Tozawa K, Morita A, Kohri K, Inagaki M (2008). Chk1 phosphorylation at Ser286 and Ser301 occurs with both stalled DNA replication and damage checkpoint stimulation. Biochem Biophys Res Commun 377, 1227-1231.
17. Jackson SP, Bartek J (2009). The DNA-damage response in human biology and disease. Nature 461, 1071-1078.
18. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, Jackson SP (2006). ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 8, 37-45. (Pubitemid 43064795)
19. Jiang K, Pereira E, Maxfield M, Russell B, Goudelock DM, Sanchez Y (2003). Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on Ser-345. J Biol Chem 278, 25207-25217. (Pubitemid 37548685)
20. Kasahara K, Goto H, Enomoto M, Tomono Y, Kiyono T, Inagaki M (2010). 14-3-3gamma mediates Cdc25A proteolysis to block premature mitotic entry after DNA damage. EMBO J 29, 2802-2812.
21. King FW, Skeen J, Hay N, Shtivelman E (2004). Inhibition of Chk1 by activated PKB/Akt. Cell Cycle 3, 634-637. (Pubitemid 40278209)
22. Kinoshita E, Kinoshita-Kikuta E, Takiyama K, Koike T (2006). Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol Cell Proteomics 5, 749-757.
23. Kinoshita-Kikuta E, Aoki Y, Kinoshita E, Koike T (2007). Label-free kinase profiling using phosphate affinity polyacrylamide gel electrophoresis. Mol Cell Proteomics 6, 356-366. (Pubitemid 46359522)
24. Lewis TS, Shapiro PS, Ahn NG (1998). Signal transduction through MAP kinase cascades. Adv Cancer Res 74, 49-139. (Pubitemid 28193546)
25. Lindsley CW (2010). The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update. Curr Top Med Chem 10, 458-477.
26. Ma CX, Janetka JW, Piwnica-Worms H (2011). Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends Mol Med 17, 88-96.
27. Mabuchi S et al. (2002). Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel. J Biol Chem 277, 33490-33500. (Pubitemid 34984873)
28. Manning BD, Cantley LC (2007). AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274. (Pubitemid 46962095)
29. Matsuyama M, Goto H, Kasahara K, Kawakami Y, Nakanishi M, Kiyono T, Goshima N, Inagaki M (2011). Nuclear Chk1 prevents premature mitotic entry. J Cell Sci 124, 2113-2119.
30. McGowan CH, Russell P (2004). The DNA damage response: sensing and signaling. Curr Opin Cell Biol 16, 629-633. (Pubitemid 39463112)
31. Meuillet EJ et al. (2010). Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor. Mol Cancer Ther 9, 706-717.
32. Mitchell JR, Hoeijmakers JH, Niedernhofer LJ (2003). Divide and conquer: nucleotide excision repair battles cancer and ageing. Curr Opin Cell Biol 15, 232-240. (Pubitemid 36332199)
33. Moniz LS, Stambolic V (2011). Nek10 mediates G2/M cell cycle arrest and MEK autoactivation in response to UV irradiation. Mol Cell Biol 31, 30-42.
34. Niida H, Nakanishi M (2006). DNA damage checkpoints in mammals. Mutagenesis 21, 3-9. (Pubitemid 43288730)
35. Nimbalkar D, Quelle FW (2008). Phosphoinositide 3-kinase signaling overrides a G2 phase arrest checkpoint and promotes aberrant cell cycling and death of hematopoietic cells after DNA damage. Cell Cycle 7, 2877-2885.
36. Nishimoto S, Nishida E (2006). MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7, 782-786. (Pubitemid 44275395)
37. Pearce LR, Komander D, Alessi DR (2010). The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol 11, 9-22.
38. Polo SE, Jackson SP (2011). Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev 25, 409-433.
39. Poteet-Smith CE, Smith JA, Lannigan DA, Freed TA, Sturgill TW (1999). Generation of constitutively active p90 ribosomal S6 kinase in vivo. Implications for the mitogen-activated protein kinase-activated protein kinase family. J Biol Chem 274, 22135-22138.
40. Puc J et al. (2005). Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 7, 193-204. (Pubitemid 40248344)
41. Reinhardt HC, Yaffe MB (2009). Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol 21, 245-255.
42. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S (2004). Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73, 39-85. (Pubitemid 39050363)
43. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, Elledge SJ (1997). Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277, 1497-1501. (Pubitemid 27449236)
44. Sapkota GP et al. (2007). BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem J 401, 29-38. (Pubitemid 46114597)
45. Sasaki R, Narisawa-Saito M, Yugawa T, Fujita M, Tashiro H, Katabuchi H, Kiyono T (2009). Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes. Carcinogenesis 30, 423-431.
46. Shiromizu T, Goto H, Tomono Y, Bartek J, Totsukawa G, Inoko A, Nakanishi M, Matsumura F, Inagaki M (2006). Regulation of mitotic function of Chk1 through phosphorylation at novel sites by cyclin-dependent kinase 1 (Cdk1). Genes Cells 11, 477-485.
47. Shtivelman E, Sussman J, Stokoe D (2002). A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle. Curr Biol 12, 919-924. (Pubitemid 34689227)
48. Tan Y, Ruan H, Demeter MR, Comb MJ (1999). p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway. J Biol Chem 274, 34859-34867. (Pubitemid 129509532)
49. Tonic I, Yu WN, Park Y, Chen CC, Hay N (2010). Akt activation emulates Chk1 inhibition and Bcl2 overexpression and abrogates G2 cell cycle checkpoint by inhibiting BRCA1 foci. J Biol Chem 285, 23790-23798.
50. Tran NL, Adams DG, Vaillancourt RR, Heimark RL (2002). Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J Biol Chem 277, 32905-32914. (Pubitemid 34984804)
51. Vivanco I, Sawyers CL (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2, 489-501. (Pubitemid 37328931)
52. Walker M, Black EJ, Oehler V, Gillespie DA, Scott MT (2009). Chk1 Cterminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity. Oncogene 28, 2314-2323.
53. Wong KK, Engelman JA, Cantley LC (2010). Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev 20, 87-90.
54. Xu N, Hegarat N, Black EJ, Scott MT, Hochegger H, Gillespie DA (2010). Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2. J Cell Biol 190, 297-305.
55. Zhao H, Piwnica-Worms H (2001). ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 21, 4129-4139. (Pubitemid 32565295)